Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6537-6543

  Boackle, Susan A ^a   Morris, Margaret A ^b   Holers, V Michael ^a   Karp, David R ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CD86 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLUENZA VIRUS; LIGATION; OPSONIZATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SERUM; T LYMPHOCYTE;

ANTIGEN PRESENTATION; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; COMPLEMENT SYSTEM PROTEINS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; MEMBRANE GLYCOPROTEINS; OPSONIN PROTEINS; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032534584     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
2. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
3. Lanzavecchia, A. 1985. Antigen-specific interactions between T and B cells. Nature 314:537.
4. Thyphronitis, G., T. Kinoshita, K. Inoue, J. E. Schweinlek, G. C. Tsokos, E. S. Metcalf, F. D. Finkelman, and J. E. Balow. 1991. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147:224.
5. Hebell, T., J. M. Ahearn, and D. T. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254:102.
6. Heyman, B., E. J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665.
7. Molina, H., V. M. Holers, B. Li, Y.-F. Fang, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357.
8. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard. T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
9. Croix, D. A., J. M. Ahearn, A. M. Rosengard, S. Han, G. Kelsoe, M. Ma, and M. C. Carroll. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857.
10. Dempsey, P. W., M. E. D. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
11. Wilson, B. S., J. L. Platt, and N. E. Kay. 1985. Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro. Blood 66:824.
12. Nemerow, G. R., M. E. McNaughton, and N. R. Cooper. 1985. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. J. Immunol. 135:3068.
13. Bohnsack, J. F., and N. R. Cooper. 1988. CR2 ligands modulate human B cell activation. J. Immunol. 141:2569.
14. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457.
15. Fingeroth, J. D., M. E. Heath, and D. M. Ambrosino. 1989. Proliferation of resting B cells is modulated by CR2 and CR1. Immunol. Lett. 21:291.
16. Luxembourg, A. T., and N. R. Cooper. 1994. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153:4448.
17. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:55.
18. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149: 2841.
19. Matsumoto, A. K., D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn, and D. T. Fearon. 1993. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407.
20. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
21. Lanzavecchia, A., S. Abrignani, D. Scheidegger, R. Obrist, B. Dorken, and G. Moldenhauer. 1988. Antibodies as antigens: the use of mouse monoclonal antibodies to focus human T cells against selected targets. J. Exp. Med. 167:345.
22. Arvieux, J., H. Yssel, and M. G. Colomb. 1988. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 65:229.
23. Thornton, B. P., V. Vetvicka, and G. D. Ross. 1994. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1727.
24. Boackle, S. A., V. M. Holers, and D. R. Karp. 1997. CD21 augments antigen presentation in immune individuals. Eur. J. Immunol. 27:122.
25. Liu, C., E. J. Gosselin, and P. M. Guyre. 1996. FcγRII on human B cells can mediate enhanced antigen presentation. Cell. Immunol. 167:188.
26. Greenman, J., A. L. Tutt, A. J. T. George, K. A. F. Pulford, G. T. Stevenson, and M. J. Glennie. 1991. Characterization of a new monoclonal anti-FcγRII antibody, AT10, and its incorporation into a biospecific F(ab′)2 derivative for recruitment of cytotoxic effectors. Mol. Immunol. 28:1243.
27. Madi, N., J. P. Paccaud, G. Steiger, and J. A. Schifferli. 1991. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1). Clin. Exp. Immunol. 84:9.
28. Dowd, J. E., R. N. Jenkins, and D. R. Karp. 1995. Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins. J. Immunol. 154:1024.
29. Karp, D. R., and E. O. Long. 1992. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E. J. Exp. Med. 175: 415.
30. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, J. Daley, G. Gray, and L. M. Nadler. 1993. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc. Natl. Acad. Sci. USA 90:11059.
31. Carel, J.-C., B. L. Myones, B. Frazier, and V. M. Holers. 1990. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. Biol. Chem. 265:12293.
32. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity 7:49.
33. Zhong, G., C. Reis e Sousa, and R. N. Germain. 1997. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J. Exp. Med. 186:673.
34. Thornton, B. P., V. Vetvicka, and G. D. Ross. 1996. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of costimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin. Exp. Immunol. 104:531.
35. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
36. Eynon, E. E., and D. C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131.
37. Gilbert, K. M., and W. O. Weigle. 1994. Tolerogenicity of resting and activated B cells. J. Exp. Med. 179:249.
38. Morris, S. C., A. Lees, and F. D. Finkelman. 1994. In vivo activation of naive T cells by antigen-presenting B cells. J. Immunol. 152:3777.
39. Wilson, J. G., W. D. Ratnoff, P. H. Schur, and D. T. Fearon. 1986. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arth. Rheum. 29:739.
40. Marquart, H. V., A. Svendsen, J. M. Rasmussen, C. H. Nielsen, P. Junker, S.-E. Svehag, and R. G. Q. Leslie. 1995. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 101:60.
41. Takahashi, K., Y. Kozono, T. J. Waldschmidt, D. Berthiaume, R. J. Quigg, A. Baron, and V. M. Holers. 1997. Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2; CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J. Immunol. 159:1557.
42. Kozono, Y., R. Abe, H. Kozono, R. G. Kelly, T. Azuma, and V. M. Holers. 1998. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160:1565.